Psilocybin-assisted therapy demonstrated long-term safety and efficacy for major depressive disorder, with two-thirds of patients remaining in complete remission at 5 years, according to a study ...
According to the paper, hundreds of thousands of people may have experienced depression linked to finasteride, and ...
Disturbances of mood and behavior in pre-adolescent children are both ubiquitous and varied. They can defy simple diagnostic ...
The final approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Paroxetine extended-release tablets of strengths 25 mg and 37.5 mg, Alembic ...
A sweeping new study that includes researchers from across the globe sheds new light on the factors influencing the suicide crisis among young people.
Additional Data from SAVITRI™ Study Expand on Top-Line Results Announced in April 2024 SAVITRI Poster Presentation Chosen as Finalist for Psych Congress Poster Awards Osavampator (NBI-1065845) is an ...
Two-thirds of clinical trial participants treated with psilocybin-assisted therapy for major depressive disorder were in complete remission from their depression five years later, a new study has ...
I think there is a misapprehension that those of us in the mental-health field who write self-help books do so from a clinical distance and without personal experience with the content that we present ...
bGerman Center for Mental Health (DZPG), Partner Site Berlin-Potsdam, Germany cGerman Center for Mental Health (DZPG), Partner Site Jena-Halle-Magedeburg, Jena, Germany dFaculty of Medicine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback